DIFFERENCES IN BONE AGE READINGS BETWEEN PEDIATRIC ENDOCRINOLOGISTS AND RADIOLOGISTS

2020 ◽  
Vol 26 (3) ◽  
pp. 328-331 ◽  
Author(s):  
Kelsey B. Eitel ◽  
Erica A. Eugster

Objective: Pediatric endocrinologists (PEs) have historically read their own bone age (BA) X-rays based on the belief that radiologists do not accurately interpret these tests. Whether there are significant differences in BA interpretations between these two groups has not been systematically explored. The objectives of the study were to compare BA readings performed by PEs and radiologists and determine whether clinical variables were associated with discrepancies in readings. Methods: A retrospective chart review of children presenting for initial evaluation of short stature (SS) or precocious puberty (PP) who had a BA X-ray completed was performed. Clinical variables analyzed included age, gender, ethnicity, Tanner stage, body mass index, reason for referral, radiologist location (Children's vs. outside hospital), and PE and radiologist BA readings using the Greulich and Pyle method. Results: Of 103 patients aged 9 ± 3.66 years, there was a discrepancy between the PE and radiologist readings on 70 images (68%). Discrepancy ranged from −1.5 to 3.5 years, with a mean of 4 ± 12 months. Patients referred for PP were more likely to have discrepant interpretations than those referred for SS (8.4 months vs. 0.8 months; P = .007). No differences were seen in interpretations between in-house radiologists and those at outside hospitals. Conclusion: Radiologists interpreted BAs differently than PEs in the majority of images. In patients referred for PP, BAs were interpreted as being older by radiologists than by PEs, perhaps due to bias from the reason for referral. Our results provide support for continued independent BA interpretations by PEs. Abbreviations: BA = bone age; GP = Greulich and Pyle; PE = pediatric endocrinologist; PP = precocious puberty; SS = short stature

Author(s):  
Jessica A. Ferris ◽  
Mitchell E. Geffner

AbstractBackground:The aim of this study was to assess aromatase inhibitor (AI) efficacy in increasing predicted adult height (PAH) and to describe clinical and biochemical safety profiles of AI-treated boys.Methods:A retrospective chart review was conducted at an academic children’s hospital endocrinology clinic. Twenty-one boys with predicted short stature and/or rapidly advancing bone age, divided as Tanner stage (TS) I–III Group 1 (G1, n=9) and TS IV–V Group 2 (G2, n=12), were treated with AIs, either letrozole or anastrozole (mean duration, G1: 2.4 years and G2: 0.9 years). Primary outcomes included PAH, hormonal/biochemical analytes, and clinical data.Results:PAH did not significantly change in either group. Mean peak testosterone significantly increased from baseline to 650±458 ng/dL (p=0.008) in G1 and to 1156±302 ng/dL (p=0.002) in G2. Estradiol did not significantly change in either group. Compared to baseline, G2 showed increased mean FSH (p=0.002), LH (p=0.002), hematocrit (p=0.0001), body mass index (BMI) z-score (p=0.0005), and acne (p=0.01).Conclusions:AIs did not increase PAH, regardless of TS. Boys in late puberty had significant increases in testosterone, gonadotropins, hematocrit, acne, and BMI, but no reduction in estradiol. The potential consequences of these findings are concerning and require long-term study, especially if AIs are started in late puberty.


2021 ◽  
pp. 1-5
Author(s):  
Lauren A. Logan ◽  
Erica A. Eugster

<b><i>Background:</i></b> A random ultrasensitive luteinizing hormone (LH) (LH-ICMA) ≥0.3 mIU/L is highly accurate in confirming a diagnosis of central precocious puberty (CPP). However, a prepubertal value does not exclude the diagnosis. The clinical differences between patients with CPP who have a pubertal versus prepubertal LH-ICMA have not been clearly defined. Furthermore, there is minimal information regarding the utility of this test in boys with CPP. The objective of this study was to analyze differences between patients diagnosed with CPP who had a pubertal versus prepubertal LH-ICMA, including a cohort of boys. <b><i>Methods:</i></b> A retrospective chart review of children diagnosed with CPP within the last 10 years who had a baseline LH-ICMA obtained was performed. Variables analyzed included sex, age, ethnicity, bone age, BMI, etiology, Tanner stage (TS), testicular volume, and menarchal status. <b><i>Results:</i></b> Of 27 boys and 126 girls who qualified for the study, the LH-ICMA was pubertal in 87% and prepubertal in 13%. Girls with a pubertal LH-ICMA had higher baseline estradiol concentrations (<i>p</i> &#x3c; 0.001) and more advanced breast development (<i>p</i> = 0.015) compared to girls with a prepubertal LH-ICMA. Of girls with a prepubertal LH-ICMA, 74% had at least TS 3 breast development and 1 was post-menarchal. The LH-ICMA was pubertal in 96% of the boys with CPP in this study. <b><i>Conclusions:</i></b> The LH-ICMA can be prepubertal even in girls with advanced development. To our knowledge, ours is the largest cohort of boys in whom the accuracy of a random LH-ICMA has been reported.


2020 ◽  
Vol 33 (6) ◽  
pp. 785-791
Author(s):  
Valeria Calcaterra ◽  
Catherine Klersy ◽  
Federica Vinci ◽  
Corrado Regalbuto ◽  
Giulia Dobbiani ◽  
...  

AbstractObjectivesData on the predictive values of parameters included in the diagnostic work-up for precocious puberty (PP) remain limited. We detected the diagnostic value of basal sex hormone levels, pelvic ultrasound parameters and bone age assessment for activation of the hypothalamic-pituitary-gonadal axis in girls with PP, in order to help in the decision to perform GnRH testing.Patients and methodsWe retrospectively considered 177 girls with PP. According to puberty evolution, the girls were divided into two groups: rapid progressive central precocious puberty (RP-CPP) and non/slowly progressive/transient forms (SP-PP). In all patients we considered Tanner stage, basal luteinizing hormone (LH) and estradiol (E2) values, bone age, and pelvis examination. We assessed the diagnostic value of each variable and identified the number of pathological parameters that best identify patients with RP-CPP.ResultsBasal LH ≥ 0.2IU/L, E2 level ≥ 50 pmol/L, uterine longitudinal diameter ≥ 3.5 cm, transverse uterine diameter ≥ 1.5 cm, endometrial echo and ovarian volume ≥ 2 cm3 were significantly associated with RP-CPP (p ≤ 0.01). The ability to diagnose RP-CPP was enhanced with increasing number of pathological hormonal and instrumental parameters (p < 0.001). With more than three parameters detected, sensitivity and specificity reached 58% (95%CI 48–67) and 85% (95%CI 74–92), respectively, with a PPV = 86% (95%CI 76–93) and PPN = 54% (95%CI 43–54); the area under the ROC curve was 0.71 (95%CI 0.65–0.78).ConclusionDespite the availability of different tests, diagnosing RP-CPP remains difficult. A diagnosis model including at least three hormonal and/or ultrasound parameters may serve as a useful preliminary step in selecting patients who require GnRH testing for early detection of RC-PP.


2021 ◽  
Vol 8 (7) ◽  
pp. 418-422
Author(s):  
Nandu Kumar Thalange ◽  
Elham Elgabaly Moustafa Ahmed ◽  
Ajay Prasanth D'Souza ◽  
Mireille El Bejjani

Objective: Artificial intelligence (AI) is playing an increasing role in patient assessment. AI bone age analysis is such a tool, but its value in Arabic children presenting to an endocrine clinic has not been explored. We compared results from an experienced pediatric radiologist and the AI bone age system, BoneXpert (BX), (Visiana, Denmark) to assess its utility in a cohort of children presenting to the Al Jalila Children’s Specialty Hospital endocrine service. Materials and Methods: We conducted a retrospective chart review of 47 children with growth disorders, initially assessed by a single experienced radiologist and subsequently by BX, to confirm the usefulness of the BX system in our population. The results of the analyses were analysed using a Bland-Altman plot constructed to compare differences between the radiologist’s interpretation and BX across the available range of bone age. Results: Forty-four of the patient x-ray images were analysed by BX. Three X-ray images were rejected by BX due to post-processing artifacts, which prevented computer interpretation. For the remaining 44 X-rays, there was a close correlation between radiologist and BX results (r=0.93; p <0.00001).  Two radiographs were identified with a large discrepancy in the reported bone ages. Blinded, independent re-evaluation of the radiographs showed the original manually interpreted bone age to have been erroneous, with the BX results corresponding closely to the amended bone age. A small positive bias was noted in bone age (+0.39 years) in the BX analyses, relative to manual interpretation. Conclusions: AI bone age analysis was of high utility in Arabic children from UAE presenting to an endocrine clinic, with results highly comparable to an experienced radiologist. In the two cases where a large discrepancy was found, independent re-evaluation showed AI analysis was correct.


2004 ◽  
Vol 89 (1) ◽  
pp. 236-241 ◽  
Author(s):  
Armando Flor-Cisneros ◽  
Ellen W. Leschek ◽  
Deborah P. Merke ◽  
Kevin M. Barnes ◽  
Marilena Coco ◽  
...  

The primary mechanism that initiates puberty is unknown. One possible clue is that pubertal maturation often parallels skeletal maturation. Conditions that delay skeletal maturation also tend to delay the onset of puberty, whereas conditions that accelerate skeletal maturation tend to hasten the onset of puberty. To examine this relationship, we studied boys with congenital adrenal hyperplasia (n = 13) and familial male-limited precocious puberty (n = 22), two conditions that accelerate maturational tempo, and boys with idiopathic short stature (n = 18) in which maturational tempo is sometimes delayed. In all three conditions, the onset of central puberty generally occurred at an abnormal chronological age but a normal bone age. Boys with the greatest skeletal advancement began central puberty at the earliest age, whereas boys with the greatest skeletal delay began puberty at the latest age. Furthermore, the magnitude of the skeletal advancement or delay matched the magnitude of the pubertal advancement or delay. This synchrony between skeletal maturation and hypothalamic-pituitary-gonadal axis maturation was observed among patients within each condition and also between conditions. In contrast, the maturation of the hypothalamic-pituitary-gonadal axis did not remain synchronous with other maturational processes including weight, height, or body mass index. We conclude that in boys with abnormal developmental tempo, maturation of the skeleton and the hypothalamic-pituitary-gonadal axis remains synchronous. This synchrony is consistent with the hypothesis that in boys, skeletal maturation influences hypothalamic-pituitary-gonadal axis maturation.


1993 ◽  
Vol 14 (4) ◽  
pp. 133-158

Skeletal maturation is expressed as bone age or skeletal age. Bone age is based on the orderly appearance of the ossification centers and, therefore, on the successive stages of the development (or maturity) of the skeleton as seen on radiographs. This is not a measure of size, but rather of shape and position. There are many methods of estimating bone age, and almost any part of the body can be used. The hand and wrist are the most practical and the most often used. The Greulich and Pyle method employs an atlas of examples of radiographs of the entire left hand and wrist of healthy children at various ages.


1999 ◽  
Vol 72 (857) ◽  
pp. 461-464 ◽  
Author(s):  
R Groell ◽  
F Lindbichler ◽  
T Riepl ◽  
L Gherra ◽  
A Roposch ◽  
...  

2010 ◽  
Vol 44 (3) ◽  
pp. 322 ◽  
Author(s):  
Ashok Shyam ◽  
SongSang Heon ◽  
Ranjith Unnikrishnan ◽  
Sang-Youn Song ◽  
HakJun Kim ◽  
...  

2020 ◽  
Vol 36 (11) ◽  
pp. 937-943
Author(s):  
Yi‐Ming Wang ◽  
Tzu‐Hsueh Tsai ◽  
Jui‐Sheng Hsu ◽  
Min‐Fang Chao ◽  
Yu‐Tsang Wang ◽  
...  

Children ◽  
2021 ◽  
Vol 8 (3) ◽  
pp. 171
Author(s):  
Seung Ah Chung ◽  
Hae Sang Lee ◽  
Seung Woo Kim ◽  
Jin Soon Hwang

We sought to determine whether the myopic progression of patients with central precocious puberty (CPP) who were undergoing treatment differed from that of their healthy peers with normal pubertal onset and progression. Eighteen girls with CPP and 14 age-matched controls who underwent regular ophthalmic examinations for at least 1 year were included. All the CPP patients received a 3.75 mg leuprolide acetate depot subcutaneously every 28 days. The spherical equivalent (SE) and axial length (AL) for myopia progression and the pubertal parameters (height, body weight, body mass index, Tanner stage, and bone age) were compared between the two groups. Of 32 subjects with a mean age of 8.6 ± 0.7 years, the SEs and ALs did not differ at baseline between the two groups, which had similar weight and similar body mass index. After 1 year, both the CPP patients and controls showed myopic progression, with an average myopic shift of −0.73 ± 0.48 diopters (D) and AL elongation with a mean change of 0.44 ± 0.61 mm. The SE and AL changes over 1 year were greater in the controls than those in the CPP patients, which was not statistically significant (–0.85 ± 0.55 D vs. –0.64 ± 0.41 D and 0.55 ± 0.89 mm vs. 0.35 ± 0.22 mm, respectively). The change in AL correlated significantly with the change in the height (β = 0.691, p = 0.039). In this 1-year study, the CPP patients with treatments trended to show less myopic progression than the controls.


Sign in / Sign up

Export Citation Format

Share Document